Anakinra in Hidradenitis Suppurativa

Anakinra in Hidradenitis Suppurativa


Anakinra in Hidradenitis Suppurativa

Acronym: null
Other IDs: HIDRA03
NCT Number: NCT01558375
Sponsor Collaborators: University of Athens
Funding: Other


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Completed
Recruiting Genders: Both
Recruiting Age Groups: Adult|Senior
Interventions: Drug: Water for injection|Drug: Anakinra
Phases: Phase 2


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Interventional
STUDY DESIGNS: Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Parallel Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Results First Received: No Study Results Posted
Study Result (if available): No Results Available
Primary Completion Date: February 2014
Outcome Measures: The efficacy of anakinra in patients with HS of Hurley II and III stage disease.|The effect of anakinra in the ex vivo function of monocytes of patients with HS.|The effect of anakinra on the time to new exacerbation|The safety of anakinra in patients with hidradenitis suppurativa


CLINICAL STUDIES DATES & MILESTONES

First Received: March 15, 2012
Start Date: March 2012
Completion Date: February 2014
Last Updated: May 26, 2015
last Verified: May 2015


Source: https://ClinicalTrials.gov/show/NCT01558375


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Translate »

Log in with your credentials

Forgot your details?